Evidence map›Paper›PMID 42744825›Full record

ArticleNature communications2026

Counteraction of HMGB1 at ss-dsDNA junctions maintains liquidity of protamine-DNA co-condensates.

Vikhyaat Ahlawat, Divya Kota, Huan-Xiang Zhou

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Vikhyaat AhlawatDepartment of Chemistry, University of Illinois Chicago, Chicago, IL, USA.
Divya KotaDepartment of Chemistry, University of Illinois Chicago, Chicago, IL, USA.
Huan-Xiang ZhouDepartment of Chemistry, University of Illinois Chicago, Chicago, IL, USA. hzhou43@uic.edu.ORCID 0000-0001-9020-0302

Funding

Quantitative, Mechanistic Studies of Biomolecular RecognitionR35GM118091 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Huan-Xiang Zhou · 2016 to 2026
$6.5M
NIGMS NIH HHS R35 GM118091U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM118091
6 · The paper itself

Abstract

In the sperm nucleus, protamine replaces histones to mediate extreme DNA compaction. The histone-to-protamine transition involves the occurrence of double-strand breaks, and is facilitated by transition proteins including those containing high-mobility-group boxes. Here we use optical tweezers and microscopy to study the actions of HMGB1 and protamine on DNA. Confocal scans of GFP-HMGB1 on overstretched λ-DNA show 2-3 foci that spread on the DNA upon retraction. Spreading of foci coincides with reannealing of ssDNA tracts, confirming their localization at ss-dsDNA junctions. Whereas the force-extension curves of protamine-soaked λ-DNA show tangles that withstand forces > 60 pN, premixing protamine with HMGB1 produces only bends and bridges ( ~ 20 pN). The counteraction of HMGB1 involves its acidic C-terminal tail, as HMGB1-ΔC fails to prevent tangle formation. In line with these single-molecule results, brightfield and confocal imaging show that protamine-dsDNA aggregates change to liquid droplets in the presence of HMGB1 but not HMGB1-ΔC. Similar to HMGB1, human transition protein 1 counteracts the effects of protamine on DNA condensation. p53, a recruiter of repair factors, colocalizes with HMGB1 and protamine at ss-dsDNA junctions. Together, these observations support our hypothesis that chromatin-associated proteins like HMGB1 help maintain early protamine-mediated DNA condensates in a liquid state to facilitate the repair of double-strand breaks.

Indexed as

Biomolecular CondensatesDNADNA, Single-StrandedHMGB1 ProteinProtaminesHistonesHumansOptical TweezersDNADNA, Single-StrandedHistonesHMGB1 ProteinProtamines

Identifiers

PMID42744825
PMCPMC13578768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.